Further molecular and clinical experiments with a larger sample size are needed to illuminate the underlying mechanism of the differential expression and methylation of FN1, PTEN, and POLR3A in the pathogenesis of CAD. This evidence concerns the gene POLR3A and coronary artery disorder.